MicroStrategy (MSTR), which earlier on Wednesday rebranded as Strategy, posted a larger-than-expected loss for the last quarter of 2024 as the Michael Saylor-founded company beefed up its ...

The company reiterated its full-year 2025 guidance of 3% to 5% organic revenue growth and 300 basis points of adjusted EBITDA margin expansion. Multiomics is expected to grow in the low single digits, ...

We hoped Allied Properties would work on their deleveraging in 2023 and 2024, but they went in the other direction. Click ...

Financial writer advises caution on investing in Merck & Co., Inc. due to negative sentiment and potential price declines.

Analyst discusses the potential for triple-digit returns with Orion S.A. if it can finally deliver on its growth projections ...

MetLife (MET) delivered Q4 earnings that beat the average analyst estimate as adjusted premiums, fees, and other revenue and ...

SoFi Technologies cannot afford to underwhelm, and its less robust guidance hasn't been taken too kindly by the market. Learn ...

Skyworks (SWKS) on Wednesday forecast a mid-to-high teens sequential decline in sales from its biggest segment for the ...

Diageo has considerable earnings downside if tariffs are implemented in the US with volumes in the market already declining.

Realty Income's dividend yield spread relative to the REIT sector is at a multi-year peak. Click here to find out why I rate ...

JD Health's operating margin is expected to improve, benefiting from fixed-cost leverage and new offerings. Click here to ...

Analysis of Spotify's impressive Q4 earnings, showing growth in subscribers, revenue, and a profitable year ahead. Click here ...